209 related articles for article (PubMed ID: 11697297)
1. [Relief for caregivers. Anti-dementia drug saves costs].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697297
[No Abstract] [Full Text] [Related]
2. [Delaying Alzheimer dementia. Patient and family relieved--costs lowered].
MMW Fortschr Med; 2000 Aug; 142(33-34):56-7. PubMed ID: 10998909
[No Abstract] [Full Text] [Related]
3. AD2000: donepezil in Alzheimer's disease.
Schneider LS
Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027
[No Abstract] [Full Text] [Related]
4. The effect of donepezil therapy on health costs in a Medicare managed care plan.
Hill JW; Futterman R; Mastey V; Fillit H
Manag Care Interface; 2002 Mar; 15(3):63-70. PubMed ID: 11925682
[TBL] [Abstract][Full Text] [Related]
5. Donepezil for the treatment of mild to moderate Alzheimer's disease in France: the economic implications.
Fagnani F; Lafuma A; Pechevis M; Rigaud AS; Traykov L; Seux ML; Forette F
Dement Geriatr Cogn Disord; 2004; 17(1-2):5-13. PubMed ID: 14560059
[TBL] [Abstract][Full Text] [Related]
6. Donepezil update.
Drug Ther Bull; 1998 Aug; 36(8):60-1. PubMed ID: 9876403
[No Abstract] [Full Text] [Related]
7. Response to "Results, rhetoric, and randomized trials: the case of donepezil".
Lisi D
J Am Geriatr Soc; 2009 Jul; 57(7):1317-8; author reply 1318. PubMed ID: 19570171
[No Abstract] [Full Text] [Related]
8. Results, rhetoric, and randomized trials: the case of donepezil.
Gilstad JR; Finucane TE
J Am Geriatr Soc; 2008 Aug; 56(8):1556-62. PubMed ID: 18662199
[TBL] [Abstract][Full Text] [Related]
9. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
Rockwood K; Black S; Bedard MA; Tran T; Lussier I;
Int J Geriatr Psychiatry; 2007 Apr; 22(4):312-9. PubMed ID: 17006874
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan.
Fuh JL; Wang SJ
Int J Geriatr Psychiatry; 2008 Jan; 23(1):73-8. PubMed ID: 17520661
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial results for donepezil in Alzheimer's disease: is the treatment glass half full or half empty?
Farlow MR
J Am Geriatr Soc; 2008 Aug; 56(8):1566-7. PubMed ID: 18808602
[No Abstract] [Full Text] [Related]
12. Economic evaluation of donepezil in moderate to severe Alzheimer disease.
Feldman H; Gauthier S; Hecker J; Vellas B; Hux M; Xu Y; Schwam EM; Shah S; Mastey V;
Neurology; 2004 Aug; 63(4):644-50. PubMed ID: 15326236
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of donepezil in moderate to severe Alzheimer disease.
van Hout HP; Bosmans JE; Stalman WA
Neurology; 2005 Apr; 64(7):1320; author reply 1320. PubMed ID: 15824386
[No Abstract] [Full Text] [Related]
14. Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation.
Getsios D; Blume S; Ishak KJ; Maclaine GD
Pharmacoeconomics; 2010; 28(5):411-27. PubMed ID: 20402542
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy, efficiency and evidence -- studies on donepezil].
Wallesch CW; Ebert AD
Fortschr Neurol Psychiatr; 2004 Oct; 72(10):555-6. PubMed ID: 15472778
[No Abstract] [Full Text] [Related]
16. How do we treat people with dementia in Croatia.
Mimica N; Presecki P
Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
[TBL] [Abstract][Full Text] [Related]
17. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
Stiles MM; Martin S; Persons RK
J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
[No Abstract] [Full Text] [Related]
18. Equity in the new NHS: hard lessons from implementing a local healthcare policy on donepezil.
Doyle Y
BMJ; 2001 Jul; 323(7306):222-4. PubMed ID: 11473920
[No Abstract] [Full Text] [Related]
19. Economic evaluation of donepezil treatment for Alzheimer's disease in Japan.
Ikeda S; Yamada Y; Ikegami N
Dement Geriatr Cogn Disord; 2002; 13(1):33-9. PubMed ID: 11731713
[TBL] [Abstract][Full Text] [Related]
20. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Gasser US; Gasser T
MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
